P & S

Drug Details

Progressive supranuclear palsy (PSP) is a rare neurological disorder that affects movement, balance, speech, swallowing, and eye movements. Typically emerging in individuals in their mid-60s, PSP results from damage to specific brain cells, leading to symptoms such as frequent falls, difficulty moving the eyes—particularly downward—and cognitive changes. Unlike Parkinson's disease, PSP progresses more rapidly and often does not respond well to medications like levodopa. While there is no cure, treatments focus on managing symptoms and improving quality of life. Complications, including pneumonia and injuries from falls, can be serious, and the condition often leads to severe disability within a few years of onset.